Related Experiment Videos
Testing for cervical Chlamydia trachomatis infection in an inner city practice
P Oakeshott1, S Chiverton, L Speight
1Mawbey Brough Health Centre, London.
Family Practice
|December 1, 1992
Summary
A study found that 8.8% of women had cervical Chlamydia trachomatis infections. Testing is recommended for high-risk individuals, particularly those with purulent vaginal discharge or inflammatory cervical smears.
Area of Science:
- Gynecology
- Infectious Diseases
- Public Health
Background:
- Cervical Chlamydia trachomatis infections are a significant public health concern.
- Early detection and treatment are crucial to prevent long-term complications.
- Screening policies need to be effective, especially in high-risk populations.
Purpose of the Study:
- To determine the prevalence of cervical Chlamydia trachomatis infection in women undergoing speculum examinations.
- To identify risk factors associated with chlamydial infection.
- To develop a rational policy for chlamydia testing in a deprived inner London practice.
Main Methods:
- A prospective study involving 409 women aged 17-45 attending for cervical smear or vaginal examination.
- Chlamydia testing performed using the direct immunofluorescent test.
- Assessment of risk factors including age, sexual history, and clinical signs like purulent vaginal discharge and cervicitis.
Main Results:
- The prevalence of cervical Chlamydia trachomatis infection was 8.8% (36 out of 409 women).
- Significant associations were found between chlamydia infection and purulent vaginal discharge or inflammatory cervical smears.
- Age, multiple sexual partners, and history of infection were assessed as potential risk factors.
Conclusions:
- Given the prevalence and potential consequences of untreated chlamydial cervicitis, universal screening for young women attending for speculum examinations is ideal.
- If universal screening is not feasible, targeted chlamydia testing should be offered to women in high-risk groups.
- Identifying women with purulent vaginal discharge or inflammatory cervical smears is key for targeted screening.